Strategic Knowledge for IVD Companies

DLMC provides expert knowledge and strategic advice to IVD developers to influence the adoption of emerging diagnostic tests and technology by licensed and accredited diagnostic laboratories. Services provided are:

    * Sales and marketing strategy
    * Development of Business proposals
    * Advice related to regulatory matters such as FDA and Health Canada
    * Focus groups facilitation, between researchers, clinicians, pathologists, laboratory
      and IVD staff
    * Tests reimbursement strategies
    * Quality requirements for adoption by licensed or accredited laboratories
    * Operational management expertise
    * Design of clinical studies to gather evidence as well as validate patient care and operational benefits
    * Access to a diagnostic network of key industry leaders and decision makers

In an ongoing engagement with a start up IVD company in Toronto, involved with microarray and multiplex technology for infectious and auto immune disease testing, DLMC provides Senior Management with expert knowledge and strategic advice to assist the company increase its market share, through replacement of less efficient predicate technology. Adoption of this novel technology by routine diagnostic laboratories provides superior operational benefits in terms of timely clinical information, quality, costs and staff productivity.

There are currently no documents for this lab test.